Prophase labs, inc. (PRPH)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Cash flows from operating activities
Net loss

-2,942

-3,146

-3,146

-3,775

-2,796

-1,740

-1,489

-1,209

-3,256

40,589

40,233

41,177

42,356

-2,868

-3,552

-3,117

-3,556

-3,600

-3,020

-6,838

-8,410

-7,834

-6,560

-2,108

-689

405

259

97

-113

-1,091

-3,376

-3,340

-2,385

-2,710

0

0

0

Adjustments to reconcile net loss to net cash provided by operating activities:
Realized loss on marketable debt securities

-12

-12

-1

-34

-118

-130

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss (gain) on sale of assets, net of taxes

-

-

-

-

-

-

-

-

-

-

42,389

42,684

43,268

0

0

0

4

9

9

15

11

6

0

0

0

-

-

-

-

-

-

-

-

28

0

0

0

Change in valuation allowance, income tax

-

-

-

-

-

-

-

-

-

1,421

-1,322

-1,027

453

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation and amortization

379

398

398

395

389

383

99

108

109

337

0

0

0

-

-

0

0

-

0

0

0

-

-

-

-

-

0

0

0

-

246

282

316

355

0

0

0

Lower of cost or net realizable value inventory adjustment

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of loan origination and warrant expenses

-

-

-

-

-

-

-

-

-

-

-

-22

-28

-24

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation expense

746

744

757

776

799

634

465

294

109

78

46

18

0

1

35

68

102

135

954

984

1,014

1,044

314

318

294

269

184

162

197

246

523

603

635

631

0

0

0

Changes in operating assets and liabilities:
Accounts receivable

447

-936

432

-625

-996

1,023

-62

-472

-1,626

-3,825

-2,720

34

722

1,770

1,067

556

-780

-1,836

-1,285

-1,098

612

517

-394

1,215

-224

-90

236

190

538

2,190

-210

-224

34

-1,602

0

0

0

Inventory

104

-444

-831

-360

-399

372

725

420

-145

-1,205

-2,206

-2,383

-1,917

-1,595

-693

644

795

1,039

711

457

1,065

771

907

-40

65

470

-141

147

-464

-637

-104

1,547

1,267

1,006

0

0

0

Prepaid and other assets

22

8

-59

-246

-343

-185

-215

-500

-37

-199

-1,316

-332

-1,286

-1,204

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable and accrued expenses

428

-14

340

137

-286

-125

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable

-

-

-

-

-

-

-

-

-

-

-

-456

-1,003

1,166

1,049

726

331

323

-1,189

-753

239

-344

810

372

314

-285

761

501

-144

411

-189

395

508

396

0

0

0

Accrued advertising and other allowances

-

-

-

-

-

-

-

-

-

-2,605

-1,010

-336

-426

297

170

-410

-1,039

-1,177

-1,038

-781

350

838

473

894

362

87

550

297

88

-199

-776

85

-322

-565

0

0

0

Other current liabilities

-61

-247

144

-435

-585

-225

-712

-28

-3,801

-1,488

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Assets held for sale, discontinued operations

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other operating assets and liabilities, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-147

1,227

973

-190

-123

-130

883

1,260

88

-145

-1,604

-1,127

-269

-1,629

-806

-882

-81

0

0

0

Accrued sales allowance, discontinued operations

-

-

-

-

-

-

-

0

0

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Assets held for sale

-

-

-

-

-

-22

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by operating activities

-1,959

-841

-1,194

-1,606

-550

-2,119

-3,064

-2,208

-6,011

-2,838

-714

-951

1,532

-472

-1,882

-4,415

-4,626

-3,497

0

0

0

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

Cash flows from investing activities
Net proceeds from the sale of assets

-

-

-

-

-

-

-

-

-

40,825

40,825

40,825

40,825

0

0

0

4

9

9

15

11

6

0

0

0

-

-

-

-

-

-

-

-

166

0

0

0

Purchase of marketable securities

0

-

-

-

-

13,350

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sale of marketable debt securities

0

-

-

-

11,055

14,280

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sale of marketable debt securities

-

-

-

-

-

11,071

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Capital expenditures

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

0

-

-

-

-

-

-

-

-

Capital expenditures

-

-

-

-

-

-

-

-

-

208

434

456

483

651

459

617

886

718

868

662

337

312

240

270

451

442

301

328

270

310

345

328

338

300

0

0

0

Net cash provided by (used in) investing activities

3,099

5,543

2,822

1,919

13,903

11,862

16,623

-7,028

-18,628

21,774

16,715

40,369

40,342

-651

-459

-617

-882

-709

0

0

0

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

Cash flows from financing activities
Payment of dividends

-

5,822

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments to retire notes

-

-

-

-

-

-

-

-

-

1,500

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds for warrants exercised

-

-

-

-

-

-

-

-

-

69

0

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,910

5,158

5,075

1,196

444

1,265

1,265

1,265

1,070

0

0

0

-

-

-

-

Net cash used in financing activities

-

-5,822

0

0

0

-

-

-

-

-16,204

-12,479

-3,287

-1,531

-100

0

0

0

-

-

-

-

4,810

5,604

5,447

362

371

-634

-560

-318

-310

0

0

0

-

-

-

-

Increase in cash and cash equivalents

-1,753

-1,120

-1,301

-2,616

-938

-1,619

-1,628

-33,615

-39,412

2,732

3,522

36,131

40,343

-1,223

-961

-2,612

-2,564

-1,262

-3,617

-3,589

-498

1,288

4,202

3,292

983

1,066

-1,064

-552

-1,732

-4,969

-2,801

-4,133

-3,318

-2,691

0

0

0

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

0

-

-

-

-

-

-

-

-

Supplemental disclosures:
Cash paid for interest

-

-

-

-

-

-

-

-

-

54

149

149

244

190

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest paid

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Supplemental disclosure of non-cash investing and financing activities:
Unrealized gain on marketable debt securities

18

22

18

52

112

54

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in escrow receivable

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Escrow receivable

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-